Literature DB >> 19245385

Defining refractory migraine: results of the RHSIS Survey of American Headache Society members.

Elliott A Schulman1, B Lee Peterlin, Alvin E Lake, Richard B Lipton, Alexandra Hanlon, Sherry Siegel, Morris Levin, Peter J Goadsby, Herbert G Markley.   

Abstract

OBJECTIVES: To gauge consensus regarding a proposed definition for refractory migraine proposed by Refractory Headache Special Interest Section, and where its use would be most appropriate.
BACKGROUND: Headache experts have long recognized that a subgroup of headache sufferers remains refractory to treatment. Although different groups have proposed criteria to define refractory migraine, the definition remains controversial. The Refractory Headache Special Interest Section of the American Headache Society developed a definition through a consensus process, assisted by a literature review and initial membership survey.
DESIGN: A 12-item questionnaire was distributed at the American Headache Society meeting in 2007 during a platform session and at the Refractory Headache Special Interest Section symposium. The same questionnaire was subsequently sent to all American Headache Society members via e-mail. A total of 151 responses from AHS members form the basis of this report. The survey instrument was designed using Survey Monkey. Frequencies and percentages of the survey were used to describe survey responses.
RESULTS: American Headache Society members agreed that a definition for refractory migraine is needed (91%) that it should be added to the International Classification of Headache Disorders-2 (86%), and that refractory forms of non-migraine headache disorders should be defined (87%). Responders believed a refractory migraine definition would be of greatest value in selecting patients for clinical drug trials. The current refractory migraine definition requires a diagnosis of migraine, interference with function or quality of life despite modification of lifestyle factors, and adequate trials of acute and preventive medicines with established efficacy. The proposed criteria for the refractory migraine definition require failing 2 preventive medications to meet the threshold for failure. Although 42% of respondents agreed with the working definition of refractory migraine, 43% favored increasing the number to 3 (50%) or 4 (26%) preventive treatment failures. When respondents were asked if they felt that the proposed definition was appropriate to select patients for invasive procedures (patent foramen ovale repair or stimulators) only 44% agreed.
CONCLUSIONS: There is a consensus for a need for a definition for refractory migraine and that it should be added to the International Classification of Headache Disorder-2. There was also general agreement by the responders that refractory forms of non-migraine headache disorders should be defined.

Entities:  

Mesh:

Year:  2009        PMID: 19245385     DOI: 10.1111/j.1526-4610.2009.01370.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  Headache.

Authors:  Peter J Goadsby
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

Review 2.  Peripheral neuromodulation in chronic migraine.

Authors:  F Perini; A De Boni
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 3.  [Therapeutic neuromodulation in primary headaches].

Authors:  A May; T P Jürgens
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 4.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 5.  Treatment of the Patient with Refractory Headache.

Authors:  Alessandro S Zagami
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

6.  Refractory migraine in a headache clinic population.

Authors:  Pablo Irimia; Jose-Alberto Palma; Roberto Fernandez-Torron; Eduardo Martinez-Vila
Journal:  BMC Neurol       Date:  2011-08-01       Impact factor: 2.474

Review 7.  Migraine in menopausal women: a systematic review.

Authors:  Patrizia Ripa; Raffaele Ornello; Diana Degan; Cindy Tiseo; Janet Stewart; Francesca Pistoia; Antonio Carolei; Simona Sacco
Journal:  Int J Womens Health       Date:  2015-08-20

8.  Relief of Secondary Headaches with High Thoracic Erector Spinae Plane Block.

Authors:  Nadia Hernandez; Grace Guvernator; George Ansoanuur; Michelle Ge; Precious Tabansi; Thanh-Thuy Le; Salameh S Obeidat; Johanna de Haan
Journal:  Local Reg Anesth       Date:  2020-06-22

9.  Neuromodulation of chronic headaches: position statement from the European Headache Federation.

Authors:  Paolo Martelletti; Rigmor H Jensen; Andrea Antal; Roberto Arcioni; Filippo Brighina; Marina de Tommaso; Angelo Franzini; Denys Fontaine; Max Heiland; Tim P Jürgens; Massimo Leone; Delphine Magis; Koen Paemeleire; Stefano Palmisani; Walter Paulus; Arne May
Journal:  J Headache Pain       Date:  2013-10-21       Impact factor: 7.277

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.